EXANE DERIVATIVES - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$11,733,000
+139.9%
1380.0%0.00%
+200.0%
Q2 2020$4,890,000
+162.9%
1380.0%0.00%0.0%
Q1 2020$1,860,000
-31.1%
1380.0%0.00%0.0%
Q4 2019$2,700,000
+47.5%
1380.0%0.00%
Q3 2019$1,830,000
-4.3%
1380.0%0.00%
Q2 2019$1,913,000
-98.3%
138
-97.7%
0.00%
-100.0%
Q1 2019$115,196,000
+259.5%
5,999
+167.1%
0.02%
+283.3%
Q4 2018$32,040,0002,2460.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders